The difference in costs between hospital-based and freestanding or private practice settings is one of the hottest topics in cancer care—and health care more broadly. It's a complex issue that is fraught with tension. Here, we review the latest studies comparing Medicare chemotherapy costs in these two settings and what hospital-based infusion centers must do to succeed in the future.